| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,744 |
25,292 |
$2.12M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,391 |
18,496 |
$1.29M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,307 |
3,704 |
$423K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,555 |
2,345 |
$366K |
| 80053 |
Comprehensive metabolic panel |
17,723 |
13,638 |
$328K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,750 |
4,000 |
$323K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,367 |
4,032 |
$318K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,275 |
6,138 |
$268K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,748 |
1,532 |
$217K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,193 |
5,622 |
$145K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,331 |
1,180 |
$137K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,035 |
912 |
$130K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
7,155 |
6,193 |
$117K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,131 |
1,066 |
$106K |
| 87070 |
|
5,492 |
5,104 |
$77K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
785 |
739 |
$64K |
| 84702 |
|
7,462 |
6,352 |
$51K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,071 |
2,666 |
$50K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
550 |
503 |
$40K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
729 |
624 |
$36K |
| G0378 |
Hospital observation service, per hour |
4,347 |
2,291 |
$36K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
868 |
721 |
$34K |
| 86850 |
|
887 |
741 |
$34K |
| A9270 |
Non-covered item or service |
7,230 |
1,520 |
$32K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,522 |
1,323 |
$32K |
| 72131 |
|
899 |
801 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,004 |
1,475 |
$31K |
| 85027 |
|
26,662 |
20,035 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,687 |
6,807 |
$30K |
| 81003 |
|
11,126 |
9,782 |
$28K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,241 |
2,872 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,959 |
10,133 |
$22K |
| 87280 |
|
2,101 |
1,974 |
$21K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,109 |
1,017 |
$19K |
| J7050 |
Infusion, normal saline solution, 250 cc |
977 |
661 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
4,809 |
4,376 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,007 |
3,623 |
$16K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
742 |
687 |
$15K |
| 87430 |
|
6,346 |
5,943 |
$15K |
| 81025 |
|
3,638 |
3,328 |
$13K |
| 73610 |
|
779 |
724 |
$12K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,347 |
8,663 |
$11K |
| 76801 |
|
1,109 |
924 |
$11K |
| 73630 |
|
945 |
873 |
$11K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
621 |
573 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
8,472 |
7,066 |
$10K |
| 73030 |
|
605 |
536 |
$9K |
| 86900 |
|
2,013 |
1,727 |
$9K |
| 81001 |
|
4,407 |
3,901 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,918 |
3,615 |
$9K |
| 73562 |
|
567 |
510 |
$9K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
1,070 |
992 |
$8K |
| 76830 |
Ultrasound, transvaginal |
733 |
653 |
$8K |
| 73130 |
|
522 |
481 |
$8K |
| 93971 |
|
494 |
444 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
571 |
509 |
$5K |
| 85610 |
|
7,825 |
6,283 |
$5K |
| 85730 |
|
6,510 |
5,373 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,343 |
1,241 |
$4K |
| 87040 |
|
2,046 |
1,548 |
$4K |
| 86901 |
|
1,965 |
1,686 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,433 |
7,434 |
$3K |
| 72128 |
|
205 |
174 |
$3K |
| 70486 |
|
125 |
116 |
$3K |
| 73590 |
|
156 |
140 |
$2K |
| 83735 |
|
7,341 |
5,044 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
716 |
606 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
553 |
234 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
105 |
79 |
$2K |
| 84484 |
|
7,119 |
4,455 |
$2K |
| 83880 |
|
2,419 |
2,016 |
$2K |
| 74022 |
|
217 |
204 |
$2K |
| 80076 |
|
3,191 |
2,799 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,044 |
3,299 |
$2K |
| 72100 |
|
214 |
193 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,354 |
1,252 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
793 |
661 |
$1K |
| 84100 |
|
2,512 |
1,537 |
$1K |
| 29125 |
|
57 |
50 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,902 |
3,296 |
$1K |
| 73110 |
|
154 |
131 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
29 |
25 |
$980.52 |
| 72170 |
|
87 |
78 |
$964.93 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,003 |
848 |
$745.46 |
| 83690 |
|
5,734 |
5,002 |
$734.70 |
| 93017 |
|
12 |
12 |
$693.42 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
705 |
543 |
$679.84 |
| 74018 |
|
13 |
13 |
$664.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,600 |
3,657 |
$646.54 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,481 |
1,936 |
$626.82 |
| 12001 |
|
15 |
14 |
$587.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,530 |
2,969 |
$584.37 |
| 93970 |
|
90 |
84 |
$583.20 |
| 74019 |
|
66 |
47 |
$551.59 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
470 |
302 |
$540.34 |
| 80061 |
Lipid panel |
719 |
563 |
$420.85 |
| 73090 |
|
66 |
62 |
$375.93 |
| 82550 |
|
1,388 |
1,063 |
$374.26 |
| 73502 |
|
27 |
24 |
$346.45 |
| 85378 |
|
1,179 |
1,042 |
$300.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,312 |
1,087 |
$286.47 |
| 71250 |
|
65 |
54 |
$280.23 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,790 |
1,664 |
$278.71 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,825 |
1,299 |
$272.41 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,057 |
940 |
$239.49 |
| J2704 |
Injection, propofol, 10 mg |
18 |
15 |
$233.56 |
| 83605 |
|
1,067 |
822 |
$220.95 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
82 |
65 |
$217.89 |
| 82077 |
|
610 |
518 |
$209.79 |
| 82248 |
|
530 |
369 |
$209.58 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,296 |
1,132 |
$183.19 |
| 85652 |
|
29 |
25 |
$182.77 |
| 73552 |
|
13 |
13 |
$174.38 |
| 87186 |
|
1,123 |
1,007 |
$156.33 |
| 73564 |
|
15 |
12 |
$102.36 |
| 87081 |
|
77 |
64 |
$52.31 |
| 80320 |
|
363 |
337 |
$33.36 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
795 |
662 |
$32.03 |
| 82553 |
|
341 |
204 |
$30.57 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
205 |
186 |
$21.72 |
| 80329 |
|
33 |
28 |
$16.84 |
| 87400 |
|
122 |
114 |
$9.89 |
| 87147 |
|
86 |
81 |
$1.64 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
207 |
188 |
$0.00 |
| 80143 |
|
103 |
92 |
$0.00 |
| 80179 |
|
109 |
99 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
58 |
51 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
134 |
107 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
15 |
13 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
46 |
31 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
45 |
25 |
$0.00 |
| 73080 |
|
41 |
37 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
103 |
63 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
133 |
104 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
77 |
57 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
68 |
48 |
$0.00 |
| C1769 |
Guide wire |
21 |
16 |
$0.00 |
| 82803 |
|
51 |
43 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
53 |
45 |
$0.00 |
| 87205 |
|
51 |
43 |
$0.00 |
| 96376 |
|
30 |
25 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
33 |
30 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
23 |
14 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
14 |
13 |
$0.00 |
| 94644 |
|
15 |
13 |
$0.00 |
| 86140 |
|
19 |
12 |
$0.00 |